(Q44192100)

30 November 2017

title

Segmental transcatheter arterial chemoembolization treatment in patients with cirrhosis and inoperable hepatocellular carcinomas (English)

1 reference

30 November 2017

0 references

4

1 reference

30 November 2017

Silvia Saccheri

1

1 reference

30 November 2017

Andrea Lovaria

2

1 reference

30 November 2017

Angelo Sangiovanni

3

1 reference

30 November 2017

Cristina De Fazio

5

1 reference

30 November 2017

Guido Ronchi

6

1 reference

30 November 2017

Pierangelo Fasani

7

1 reference

30 November 2017

Ersilio Del Ninno

8

1 reference

30 November 2017

Massimo Colombo

9

1 reference

30 November 2017

publication date

1 October 2002

1 reference

Journal of Vascular and Interventional Radiology

30 November 2017

published in

1 reference

30 November 2017

volume

13

1 reference

30 November 2017

issue

10

1 reference

30 November 2017

page(s)

995-999

1 reference

Treatment of hepatocellular carcinoma

30 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961863-6

7 January 2021

Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961863-6

7 January 2021

Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: resection versus transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961863-6

7 January 2021

Hepatocellular carcinoma and cirrhosis in 746 patients: long-term results of percutaneous ethanol injection

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961863-6

7 January 2021

Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961863-6

7 January 2021

A randomized trial of hepatic arterial chemoembolization in patients with unresectable hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961863-6

7 January 2021

Treatment of unresectable hepatocellular carcinoma with lipiodol chemoembolization: a multicenter randomized trial. Groupe CHC

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961863-6

7 January 2021

A comparison of lipiodol chemoembolization and conservative treatment for unresectable hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961863-6

7 January 2021

Segmental embolotherapy for hepatic cancer: keys to success

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961863-6

7 January 2021

Small hepatocellular carcinoma: treatment with subsegmental transcatheter arterial embolization

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961863-6

7 January 2021

No treatment, resection and ethanol injection in hepatocellular carcinoma: a retrospective analysis of survival in 391 patients with cirrhosis. Italian Cooperative HCC Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961863-6

7 January 2021

Natural history of untreated nonsurgical hepatocellular carcinoma: rationale for the design and evaluation of therapeutic trials

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961863-6

7 January 2021

Transection of the oesophagus for bleeding oesophageal varices

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961863-6

7 January 2021

Performance status assessment in cancer patients. An inter-observer variability study

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961863-6

7 January 2021

Determination of the optimum dose level of lipiodol in transcatheter arterial embolization of primary hepatocellular carcinoma based on retrospective multivariate analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961863-6

7 January 2021

Reporting results of cancer treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961863-6

7 January 2021

Transarterial embolization versus symptomatic treatment in patients with advanced hepatocellular carcinoma: results of a randomized, controlled trial in a single institution.

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961863-6

7 January 2021

Influence of preoperative transarterial lipiodol chemoembolization on resection and transplantation for hepatocellular carcinoma in patients with cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961863-6

7 January 2021

Vascularization of small hepatocellular carcinomas: correlation with differentiation

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961863-6

7 January 2021

10.1016/S1051-0443(07)61863-6

Identifiers

DOI

1 reference

30 November 2017

1 reference